SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Kaman Corporation (KAMN) trades at a trailing P/E of 164.3. Trailing earnings yield is 0.61%.
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 164.3); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY 0.61%).
- Trailing Earnings Yield 0.61% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
Overall SharesGrow Score: 40/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — KAMN
Valuation Multiples
P/E (TTM)164.3
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.68
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.28
Book Value / Share$0.00
Revenue / Share$27.37
FCF / Share$0.00
Yields & Fair Value
Earnings Yield0.61%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$2.08 |
$1.79B |
$57.87M |
3.2% |
| 2015 |
$2.17 |
$1.78B |
$60.44M |
3.4% |
| 2016 |
$2.10 |
$1.81B |
$58.85M |
3.3% |
| 2017 |
$1.75 |
$1.81B |
$49.83M |
2.8% |
| 2018 |
$1.92 |
$1.88B |
$54.17M |
2.9% |
| 2019 |
$2.01 |
$761.61M |
$56.45M |
7.4% |
| 2020 |
$-2.54 |
$784.46M |
$-70.43M |
-9% |
| 2021 |
$1.57 |
$708.99M |
$43.67M |
6.2% |
| 2022 |
$-1.65 |
$687.96M |
$-46.23M |
-6.7% |
| 2023 |
$0.28 |
$775.85M |
$7.95M |
1% |
